Description
A summary of major trends in the IVD industry, from harmonization to Cardiac marker testing.
Published on: June 7, 2018
Table of Contents
- In this issue
- 3 Indidcations Regulators are Building a Pathway for Clinical Sequencing-Based Tests
- Cardiac Markers
- Harmonization of Lab Tests
IVD Procedure Volumes 2020-2025
February 23, 2021
COVID-19 Testing Update 2021: Molecular & Antigen Markets, Procedures, Mutations, Home Tests, and Other Trends
February 16, 2021
The Market and Future Potential for Molecular Point of Care
January 22, 2021
Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications
January 1, 2005- Price: $3,500.00 – $7,000.00
Diagnostics for Emerging Infectious Disease Threats Volume III: Bacterial Disease
April 1, 2004- Price: $1,995.00 – $3,990.00
Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential
October 1, 2004- Price: $995.00 – $1,990.00
Cell-Based Diagnostics: Technology, Applications, and Markets
January 1, 2005- Price: $3,500.00 – $7,000.00
Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- COVID-19 Diagnostics Market Blog: FDA Tightens on Variants, Thermo Launches 8,000 Sample/Day COVID-19 Test; Quest Tasked by CDC to Identify COVID-19 Mutations; COVID-19 One Year Later, Ellume Home Test, Visby and More February 24, 2021
- Molecular Point of Care Test Market Nearly Triples in One Year, Due to COVID-19. January 26, 2021
- COVID-19 Pandemic Accelerates Adoption of Diagnostic Testing at Point of Care January 12, 2021
- Science and Medicine Groups Predictions for 2021 in the Lab Instrumentation, Diagnostics and Imaging Industries January 7, 2021
- For Roche, Alignment Between Tests and COVID-19 Vaccines is Key December 14, 2020
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group